The ginsenoside, Rb1, may treat obesity by modifying the serum content and mRNA expressions of neuropeptide Y (NPY), NPY Y2 receptor, and peptide YY (PYY). The gene discussed is NPY; the disease is obesity due to melanocortin 4 receptor deficiency.